Laparoscopic Portoenterostomy (Kasai Operation)

Access the accompanying videos for this chapter online. Available on .

Despite the first successful surgical treatment for correctable biliary atresia (BA) being reported in 1928, very few patients with correctable BA survived long term. In 1959, Professor Kasai described his hepatic portoenterostomy procedure for the first time and ended a long, hopeless era for patients with BA. Unfortunately, Kasai’s original portoenterostomy (KOPE) technique was published in Japanese and received little attention until it was published in English in 1968. However, the original KOPE was soon modified in an attempt achieve better rates of jaundice clearance (JC) and survival with the native liver (SNL), to the point that the current Kasai portoenterostomy (KP) involves an extended lateral dissection with a very wide anastomosis (extended portoenterostomy [EPE]) that hardly resembles Kasai’s original procedure. Nevertheless, this modified technique is still probably the most widely used open technique for treating BA.

The first laparoscopic KP procedure was described in 2002. Since then, few other studies have been reported, probably because of a combination of technical difficulty and negative research findings showing compromised liver perfusion during pneumoperitoneum causing liver cell damage, and elevated intra-abdominal pressure causing decreased proliferation and inducing apoptosis in hepatocytes in a rat model, as well as several reports of worse early clinical outcomes compared with the open KP.

The laparoscopic KP performed at Juntendo and described in this chapter is a modified version of KOPE, executed according to Kasai’s principles using minimally invasive surgery (MIS). In laparoscopic KOPE (LK), dissection of the porta hepatis is confined to the area around the base of the fibrous biliary remnant, which is transected shallowly to limit the extent of the transected surface and sutured shallowly around the outer edge of the biliary remnant to prevent injuring the microbile ducts at the 2- and 10- o’clock positions. These are KOPE principles. Interestingly, since embarking on our mission to incorporate the principles of KOPE rather than persevere with EPE, some centers have taken our lead and started applying our concepts when performing the open KP.

Indications for Workup and Operation

Signs suggestive of BA include jaundice, pale stools, dark urine, and hepatomegaly. Unfortunately, there is no single clinical feature with sufficient sensitivity and specificity to differentiate BA from other causes of neonatal jaundice. Thus neonatal jaundice that persists for more than 2 weeks should be investigated at a tertiary health care facility. Meconium staining may be normal, and feces may be yellow during the neonatal period in more than half of patients, but the urine gradually turns dark brown. Although the liver is diseased, the bilirubin is conjugated, and kernicterus is not usually a concern in BA. Early diagnosis is mandatory, and investigations should not be protracted because treatment will be delayed.

Many protocols have been suggested, but the diagnostic workup should always include ultrasonography, biochemical exclusion of α1-antitrypsin deficiency and cystic fibrosis, liver scintigraphy, and a percutaneous liver biopsy. The histological appearance of the liver is characterized by portal tract edema, bile duct plugging and proliferation, a small cell infiltrate, and variable amounts of giant cell formation. Bridging fibrosis is a late feature but in some cases may be present even at diagnosis. Using this protocol, about 80% of affected infants will have a positive diagnosis prior to operation. However, a liver biopsy can be traumatic and specimens require histopathologic assessment for accuracy, which can be time consuming.

While percutaneous liver biopsy is often performed, laparoscopic inspection provides the opportunity to diagnose liver cirrhosis and gallbladder atrophy. Diagnostic laparoscopy also allows cholangiography to be performed if the gallbladder is not atrophic to identify the intrahepatic bile ducts and common bile duct (CBD) to diagnose/exclude BA. Liver scintigraphy is typically abnormal in BA, with rapid uptake by hepatocytes and virtually no excretion into the bowel, even on delayed images. Laboratory investigations should include conventional liver function tests plus γ-glutamyl transpeptidase, TORCH (toxoplasmosis, other, rubella, cytomegalovirus, and herpes simplex) titers, and coagulation tests to exclude vitamin K–dependent coagulopathy.

All infant cases of BA should have parenteral vitamin K (phytomenadione, 1.0 mg/day) supplementation, usually given for several days prior to operation. The bowel should be prepared with oral kanamycin. Oral feeding is discontinued 24 to 48 hours before the operation and glycerin enemas are given. Broad-spectrum antibiotics are administered preoperatively. Our protocol is to administer antibiotics intravenously in the operating room and continue them postoperatively until the C-reactive protein (CRP) is less than 0.3 mg/dL or the leukocytosis has resolved.

Operative Technique

The baby is positioned at the foot of the operating table, and the operating surgeon stands at the infant’s feet. An assistant/camera operator is situated slightly behind and to the left of the operating surgeon, and another assistant is located on the patient’s right to assist with exposing the porta hepatis and the anastomosis. The anesthetist is positioned near the baby’s head and the scrub nurse is situated to the left of the baby ( Fig. 22-1A ). The monitor is located above the infant’s head facing the operating surgeon. Vascular access, nasogastric tube insertion, and bladder catheterization are then performed.

Fig. 22-1

A, The baby is positioned at the foot of the operating table with the operating surgeon (S) standing at the infant’s feet. A scopist (SC) is situated slightly behind and to the left of the operating surgeon, and an assistant (SA) is positioned on the patient’s left to assist with exposing the porta hepatis and the anastomosis. The scrub nurse (SN) stands to the left of the patient and the anesthetist is located near the patient’s head. A single monitor is (M) positioned at the patient’s head, facing the operating personnel. B, The five ports are situated as depicted on this schematic. A 10-mm and 5-mm cannula are introduced inside the EZ access with the LAP PROTECTOR device. The other ports are 5 mm in size. A Nathanson liver retractor (dotted line) is also helpful for the laparoscopic Kasai procedure.

Access Points

A flexible silicon wound retractor (LAP PROTECTOR) with a silicon cap (EZ Access; both Hakko Medical, Nagano, Japan) is inserted through a 20-mm umbilical incision ( Fig. 22-1B ). A 10-mm cannula, for a 30-degree 5- or 10-mm laparoscope, and a 5-mm cannula for retraction are placed via the EZ Access/LAP PROTECTOR. Three additional ports are then positioned under laparoscopic visualization. Two 5-mm cannulas are inserted on either side of the upper quadrant port for the surgeon’s right and left hands, slightly above the level of the umbilicus, and just lateral to the rectus abdominis. Another 5-mm port is introduced in the epigastrium for the Ligasure device (Valley Lab, Boulder, CO) or 3-mm Vessel Sealing System (Bolder Surgical Inc., Louisville, CO) (see Fig. 22-1B ). Cannulas are stabilized by fixing with sutures and rubber O-rings to prevent dislodgement.

Dissection of Biliary Remnants and the Porta Hepatis

Adequate exposure of the porta hepatis is crucial for performing LK safely and is helped by introducing a percutaneous polydioxanone stay suture (PDS II 3-0, Ethicon Inc., Somerville, NJ) just below the xiphoid process to snare the round and falciform ligaments and elevate/retract the liver ( Fig. 22-2A ). Two additional percutaneous stay sutures are then placed in the parenchyma of both the right and left lobes to elevate the liver to further expose the porta hepatis ( Fig. 22-2B ). A Nathanson retractor (Mediflex Surgical Products, Islandia, NY) is inserted through an epigastric incision slightly to the right of the xiphoid process and is very effective for exposing the porta hepatis for anastomosis. The cystic duct and the mid to distal biliary remnant are dissected using a combination of hook diathermy, Ligasure, the 3-mm sealing device, and tissue forceps. The fibrotic biliary remnant is then ligated with an Endo Clip (Covidien, Mansfield, MA) and transected distally at the superior border of the duodenum with scissors ( Fig. 22-3 ). The distal end of the biliary remnant is elevated to enable the important portal structures (right and left hepatic arteries and the bifurcation of the main portal vein) to be visualized ( Fig. 22-4 ). A Ligasure or the 3-mm vessel sealer is inserted through the 5-mm port placed in the epigastrium and is used to dissect the biliary remnant and divide the portal vein branches at the porta hepatis draining into the caudate lobe. These sealing devices ( Fig. 22-5 ) generate much less lateral thermal energy compared with high-current monopolar hook diathermy, which is favored by many laparoscopic surgeons but causes unacceptable lateral thermal injury to the microscopic bile ducts in the biliary remnant. The level of transection ( Figs. 22-6 and 22-7 ) in our LK technique follows the principles of KOPE ( Figs. 22-8A and 22-8B ) and does not attempt to emulate the EPE technique ( Fig. 22-8C ).

Fig. 22-2

Percutaneous polydioxanone stay sutures are very helpful for exposing the porta hepatis . A, One of the stay sutures is introduced below the xiphoid process to elevate the round and falciform ligaments, which helps improve retraction of the liver. B, Two stay sutures are inserted into the parenchyma of both the right and left lobes to further elevate the liver.

Only gold members can continue reading. Log In or Register to continue

Stay updated, free articles. Join our Telegram channel

Apr 3, 2021 | Posted by in GASTOINESTINAL SURGERY | Comments Off on Laparoscopic Portoenterostomy (Kasai Operation)

Full access? Get Clinical Tree

Get Clinical Tree app for offline access